Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-24 | Dr. Rachesky holds an MBA from the Stanford University School of Business, an MD from the Stanford University School of Medicine and a BA in Molecular Aspects of Cancer from the University of Pennsylvania. |
| 2016-04-22 | Dr. Rachesky holds an MBA from the Stanford University School of Business, an MD from the Stanford University School of Medicine and a BA in Molecular Aspects of Cancer from the University of Pennsylvania. |
| 2017-04-28 | Dr. Rachesky is Founder and President of MHR Fund Management LLC, with an MD and MBA, and experience in investment management. |
| 2018-04-27 | Dr. Rachesky holds an MBA from the Stanford University School of Business, an MD from the Stanford University School of Medicine and a BA in Molecular Aspects of Cancer from the University of Pennsylvania. |
| 2019-04-26 | Dr. Rachesky holds an MBA from the Stanford University School of Business, an MD from the Stanford University School of Medicine and a BA in Molecular Aspects of Cancer from the University of Pennsylvania. |
| 2020-04-28 | Dr. Rachesky holds an MBA from the Stanford University School of Business, an MD from the Stanford University School of Medicine and a BA in Molecular Aspects of Cancer from the University of Pennsylvania. Dr. Rachesky has demonstrated leadership skills as well as extensive financial expertise and broad-based business knowledge. |
| 2021-04-30 | Dr. Rachesky holds an MBA from the Stanford University School of Business, an MD from the Stanford University School of Medicine and a BA in Molecular Aspects of Cancer from the University of Pennsylvania. |
| 2022-04-19 | Dr. Rachesky holds an MBA from the Stanford University School of Business, an MD from the Stanford University School of Medicine and a BA in Molecular Aspects of Cancer from the University of Pennsylvania. |
| 2023-04-26 | Dr. Rachesky holds an MBA, an MD, and a BA in Molecular Aspects of Cancer; his expertise is in investment and business leadership. |
| 2024-04-24 | Dr. Rachesky holds an MBA, an MD, and a BA in Molecular Aspects of Cancer; he is an investment professional with no mention of software skills. |
Data sourced from SEC filings. Last updated: 2025-10-11